Precision Medicine

Standard clinical practice often requires patients to wait months to determine if a Selective Serotonin Reuptake Inhibitor is effective, leading to significant emotional and financial burdens. This trial-and-error approach remains the dominant method for addressing Major Depressive Disorder, a

Beyond whole chromosome counts, specific variations in the CFHR3 and TNFRSF4 genes are linked to the disruption of immune tolerance required to maintain a healthy pregnancy. For approximately one percent of couples worldwide, the journey toward parenthood is interrupted by recurrent pregnancy loss,

The approval of Guardant360 CDx as a companion diagnostic for AstraZeneca’s camizestrant marks the first time a liquid biopsy has been authorized for continuous monitoring of cancer evolution. This regulatory milestone fundamentally alters the management of advanced breast cancer by allowing

The pharmaceutical industry is experiencing a defining transformation as the first patient recently began treatment in the GENESIS-IPF-3 Phase III clinical trial. Academician Nanshan Zhong and President Chang Chen are among the elite medical professionals overseeing the multi-center clinical effort

The development of a connected nationwide ecosystem for cellular therapy is designed to standardize the quality of regenerative care across every Malaysian state. This ambitious shift is currently reshaping the biotechnology sector, where the focus has moved from being a passive consumer of

While immunotherapy was previously confined to treating advanced stages of the disease, new evidence shows its efficacy in earlier, resectable settings. Gastric cancer has long remained a formidable opponent within the global oncology landscape, currently ranking as the fifth most common cancer